Moderna, Inc. (MRNA)
Price:
29.48 USD
( - -0.15 USD)
Your position:
0 USD
ACTION PANEL
ABOUT
Check the
KEY TAKEAWAYS
ASK OUR AI ABOUT THE COMPANY (REGISTER FOR EARLY ACCESS)
(REGISTER FOR EARLY ACCESS) CHOOSE A PROMPT ABOVE TO ASK OUR AI ABOUT THE SPECIFIC INFORMATION
SIMILAR COMPANIES STI SCORE
Similar STI Score
Regeneron Pharmaceuticals, Inc.
VALUE SCORE:
6
2nd position
ADMA Biologics, Inc.
VALUE SCORE:
11
The best
Genmab A/S
VALUE SCORE:
11
FUNDAMENTALS
FUNDAMENTALS
FUNDAMENTALS
FUNDAMENTALS PER SHARE
TECHNICAL
DIVIDEND
SIMILAR COMPANIES
DESCRIPTION
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, respiratory syncytial virus, Endemic HCoV, and hMPV+PIV3 vaccines; latent vaccines comprise cytomegalovirus, epstein-barr virus, human immunodeficiency virus, herpes simplex virus, and varicella-zoster virus vaccines; and public health vaccines consists of Zika and Nipah vaccines. The company also offers systemic secreted and cell surface therapeutics; cancer vaccines, such as personalized cancer, KRAS, and checkpoint vaccines; intratumoral immuno-oncology products; localized regenerative, systemic intracellular, and inhaled pulmonary therapeutics. It has strategic alliances with AstraZeneca PLC; Merck & Co., Inc.; Vertex Pharmaceuticals Incorporated; Vertex Pharmaceuticals (Europe) Limited; Carisma Therapeutics, Inc.; Metagenomi, Inc.; the Defense Advanced Research Projects Agency; Biomedical Advanced Research and Development Authority; Institute for Life Changing Medicines; and The Bill & Melinda Gates Foundation, as well as a collaboration and license agreement with Chiesi Farmaceutici S.P.A. The company was formerly known as Moderna Therapeutics, Inc. and changed its name to Moderna, Inc. in August 2018. Moderna, Inc. was founded in 2010 and is headquartered in Cambridge, Massachusetts.
NEWS
Market Today: Tech Slumps, Broadcom Tanks; EU Eases ICE Ban
gurufocus.com
2025-12-12 17:35:00Stock News Tech-led selloff caps tough week: US stocks fell as investors rotated out of mega-cap tech after Broadcom (AVGO) and Oracle (ORCL) stoked AI-spending
FDA Weighs Black Box Warning For COVID Vaccines, Experts Push Back
feeds.benzinga.com
2025-12-12 13:51:10FDA officials are weighing a black box warning for Covid vaccines, a proposal that has drawn strong criticism from outside experts citing lack of evidence.
Moderna 2026 Covid and RSV growth not enough to boost stock, Jefferies says
proactiveinvestors.com
2025-12-12 11:42:09Moderna Inc (NASDAQ:MRNA, XETRA:0QF) has been awarded a ‘Hold' rating and $30 price target, implying limited upside, from Jefferies analysts in their initial coverage of the drugmaker. Moderna shares are down almost 28% in the year to date, trading just shy of $30 on Friday morning.
Here Are Friday’s Top Wall Street Analyst Research Calls: Bristol-Myers Squibb, Citigroup, Lululemon Athletica, PayPal, Roblox, Soundhound AI, and More
247wallst.com
2025-12-12 08:13:25Pre-Market Stock Futures: The futures are trading mixed as we get set to close out a wild and woolly week that saw a touch of just about everything. The Federal Reserve, as expected, cut rates again and indicated that another cut could come in 2026. Oracle Corp. (NASDAQ: ORCL), which has been on fire this... Here Are Friday's Top Wall Street Analyst Research Calls: Bristol-Myers Squibb, Citigroup, Lululemon Athletica, PayPal, Roblox, Soundhound AI, and More.
Moderna 2026 Covid and RSV growth not enough to boost stock, Jefferies says
proactiveinvestors.com
2025-12-12 06:39:00Moderna Inc (NASDAQ:MRNA, XETRA:0QF) has been awarded a ‘Hold’ rating and $30 price target, implying limited upside, from Jefferies analysts in their...
U.S. Global Investors to continue monthly dividends; highlights strong performance of gold, silver and airline sector
proactiveinvestors.com
2025-12-12 06:03:00U.S. Global Investors (NASDAQ:GROW) announced that it will maintain its monthly dividend payments, with $0.0075 per share scheduled for January through...
Roivant Signals Major Pipeline Momentum With Accelerated Timelines
feeds.benzinga.com
2025-12-11 13:39:24Roivant (NASDAQ: ROIV) outlined accelerated timelines and expanded commercial ambitions for several late-stage programs.
Amundi Sells 425,861 Shares of Moderna, Inc. $MRNA
defenseworld.net
2025-12-10 03:25:07Amundi reduced its position in shares of Moderna, Inc. (NASDAQ: MRNA) by 31.9% during the undefined quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 909,429 shares of the company's stock after selling 425,861 shares during the quarter. Amundi owned about 0.23% of Moderna worth
Moderna (MRNA) Recently Broke Out Above the 50-Day Moving Average
zacks.com
2025-12-08 10:31:26Moderna (MRNA) reached a significant support level, and could be a good pick for investors from a technical perspective. Recently, MRNA broke through the 50-day moving average, which suggests a short-term bullish trend.
Moderna (MRNA) Just Reclaimed the 200-Day Moving Average
zacks.com
2025-12-08 10:31:22From a technical perspective, Moderna (MRNA) is looking like an interesting pick, as it just reached a key level of support. MRNA recently overtook the 200-day moving average, and this suggests a long-term bullish trend.
Moderna (MRNA) Recently Broke Out Above the 20-Day Moving Average
zacks.com
2025-12-04 10:35:30Moderna (MRNA) is looking like an interesting pick from a technical perspective, as the company reached a key level of support. Recently, MRNA crossed above the 20-day moving average, suggesting a short-term bullish trend.
First Look: Insurers, Auto Rules, AI and Fed Jitters
gurufocus.com
2025-12-04 07:38:00Stock News Insurers under pressure, prior auth pledges stall: UnitedHealth Group (UNH) and peers Cigna (CI), Humana (HUM), CVS Health (CVS) and Elevance Health
Moderna, Inc. (MRNA) Presents at Piper Sandler 37th Annual Healthcare Conference Transcript
seekingalpha.com
2025-12-02 13:33:29Moderna, Inc. (MRNA) Presents at Piper Sandler 37th Annual Healthcare Conference Transcript
Dow Jones Today: Stocks Gain After Major Indexes Snap 5-Session Winning Streaks; Tech, Crypto-Tied Shares Rebound
investopedia.com
2025-12-02 12:00:21Stocks rose slightly Tuesday, a day after the three major equities indexes ended their runs of five consecutive winning sessions.
Vaccine Stocks Fall After FDA Plans to Impose Stricter Vaccine Rules
zacks.com
2025-12-02 10:41:12Shares of vaccine makers slide as an internal FDA memo on vaccine safety and plans for stricter rules spark broad pressure across the overall industry.
Dow Jones Today: Stock Indexes Close Lower to Begin December Trading; Big Tech, Crypto-Tied Shares Drop Amid Risk-Off Sentiment
investopedia.com
2025-12-01 20:00:43Major stock indexes pulled back as the final trading month of the year began, with shares of big tech and cryptocurrency-tied firms falling amid risk-off sentiment.
No data to display
Market Today: Tech Slumps, Broadcom Tanks; EU Eases ICE Ban
gurufocus.com
2025-12-12 17:35:00Stock News Tech-led selloff caps tough week: US stocks fell as investors rotated out of mega-cap tech after Broadcom (AVGO) and Oracle (ORCL) stoked AI-spending
FDA Weighs Black Box Warning For COVID Vaccines, Experts Push Back
feeds.benzinga.com
2025-12-12 13:51:10FDA officials are weighing a black box warning for Covid vaccines, a proposal that has drawn strong criticism from outside experts citing lack of evidence.
Moderna 2026 Covid and RSV growth not enough to boost stock, Jefferies says
proactiveinvestors.com
2025-12-12 11:42:09Moderna Inc (NASDAQ:MRNA, XETRA:0QF) has been awarded a ‘Hold' rating and $30 price target, implying limited upside, from Jefferies analysts in their initial coverage of the drugmaker. Moderna shares are down almost 28% in the year to date, trading just shy of $30 on Friday morning.
Here Are Friday’s Top Wall Street Analyst Research Calls: Bristol-Myers Squibb, Citigroup, Lululemon Athletica, PayPal, Roblox, Soundhound AI, and More
247wallst.com
2025-12-12 08:13:25Pre-Market Stock Futures: The futures are trading mixed as we get set to close out a wild and woolly week that saw a touch of just about everything. The Federal Reserve, as expected, cut rates again and indicated that another cut could come in 2026. Oracle Corp. (NASDAQ: ORCL), which has been on fire this... Here Are Friday's Top Wall Street Analyst Research Calls: Bristol-Myers Squibb, Citigroup, Lululemon Athletica, PayPal, Roblox, Soundhound AI, and More.
Moderna 2026 Covid and RSV growth not enough to boost stock, Jefferies says
proactiveinvestors.com
2025-12-12 06:39:00Moderna Inc (NASDAQ:MRNA, XETRA:0QF) has been awarded a ‘Hold’ rating and $30 price target, implying limited upside, from Jefferies analysts in their...
U.S. Global Investors to continue monthly dividends; highlights strong performance of gold, silver and airline sector
proactiveinvestors.com
2025-12-12 06:03:00U.S. Global Investors (NASDAQ:GROW) announced that it will maintain its monthly dividend payments, with $0.0075 per share scheduled for January through...
Roivant Signals Major Pipeline Momentum With Accelerated Timelines
feeds.benzinga.com
2025-12-11 13:39:24Roivant (NASDAQ: ROIV) outlined accelerated timelines and expanded commercial ambitions for several late-stage programs.
Amundi Sells 425,861 Shares of Moderna, Inc. $MRNA
defenseworld.net
2025-12-10 03:25:07Amundi reduced its position in shares of Moderna, Inc. (NASDAQ: MRNA) by 31.9% during the undefined quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 909,429 shares of the company's stock after selling 425,861 shares during the quarter. Amundi owned about 0.23% of Moderna worth
Moderna (MRNA) Recently Broke Out Above the 50-Day Moving Average
zacks.com
2025-12-08 10:31:26Moderna (MRNA) reached a significant support level, and could be a good pick for investors from a technical perspective. Recently, MRNA broke through the 50-day moving average, which suggests a short-term bullish trend.
Moderna (MRNA) Just Reclaimed the 200-Day Moving Average
zacks.com
2025-12-08 10:31:22From a technical perspective, Moderna (MRNA) is looking like an interesting pick, as it just reached a key level of support. MRNA recently overtook the 200-day moving average, and this suggests a long-term bullish trend.
Moderna (MRNA) Recently Broke Out Above the 20-Day Moving Average
zacks.com
2025-12-04 10:35:30Moderna (MRNA) is looking like an interesting pick from a technical perspective, as the company reached a key level of support. Recently, MRNA crossed above the 20-day moving average, suggesting a short-term bullish trend.
First Look: Insurers, Auto Rules, AI and Fed Jitters
gurufocus.com
2025-12-04 07:38:00Stock News Insurers under pressure, prior auth pledges stall: UnitedHealth Group (UNH) and peers Cigna (CI), Humana (HUM), CVS Health (CVS) and Elevance Health
Moderna, Inc. (MRNA) Presents at Piper Sandler 37th Annual Healthcare Conference Transcript
seekingalpha.com
2025-12-02 13:33:29Moderna, Inc. (MRNA) Presents at Piper Sandler 37th Annual Healthcare Conference Transcript
Dow Jones Today: Stocks Gain After Major Indexes Snap 5-Session Winning Streaks; Tech, Crypto-Tied Shares Rebound
investopedia.com
2025-12-02 12:00:21Stocks rose slightly Tuesday, a day after the three major equities indexes ended their runs of five consecutive winning sessions.
Vaccine Stocks Fall After FDA Plans to Impose Stricter Vaccine Rules
zacks.com
2025-12-02 10:41:12Shares of vaccine makers slide as an internal FDA memo on vaccine safety and plans for stricter rules spark broad pressure across the overall industry.
Dow Jones Today: Stock Indexes Close Lower to Begin December Trading; Big Tech, Crypto-Tied Shares Drop Amid Risk-Off Sentiment
investopedia.com
2025-12-01 20:00:43Major stock indexes pulled back as the final trading month of the year began, with shares of big tech and cryptocurrency-tied firms falling amid risk-off sentiment.